...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: New RVX Tweet
6
Jul 28, 2020 03:46PM
12
Jul 28, 2020 04:26PM
9
Jul 28, 2020 04:54PM
1
Jul 28, 2020 05:23PM
6
Jul 28, 2020 07:30PM

KK2 - From the June 22 PR - BoM2 

All or most BETonMACE2 patients to receive top standard of care, including maximized use of SGLT2 inhibitors (SGLT2i)

BETonMACE2 to increase enrichment of chronic kidney disease (CKD) patients, potentially including those with lower baseline renal function

Based on BETonMACE results, the FDA encouraged the evaluation of a non-alcoholic fatty liver disease (NAFLD) subgroup as well as related exploratory endpoints

Just some small changes that could have a profound effect on the final outcome as it was these groups that had the best results in BETonMACE.

Best to have the scientists chime in as I am not in that catagory.

tada

 

4
Jul 31, 2020 09:44AM
2
Jul 31, 2020 01:31PM
3
Jul 31, 2020 01:49PM
2
Jul 31, 2020 06:14PM
2
Jul 31, 2020 06:16PM
3
Jul 31, 2020 06:33PM
4
Aug 01, 2020 04:22AM
6
Aug 01, 2020 08:32AM
7
Aug 01, 2020 11:52AM
3
Aug 01, 2020 03:10PM
3
Aug 01, 2020 03:14PM
6
Aug 01, 2020 09:09PM
7
Aug 02, 2020 03:42PM
4
Aug 02, 2020 09:39PM
5
Aug 04, 2020 12:15AM
3
Aug 04, 2020 04:16AM
1
Aug 04, 2020 07:30AM
7
Aug 04, 2020 10:35AM
5
Sep 04, 2020 07:38PM
Share
New Message
Please login to post a reply